Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (673)

1

COVID-19 Australia : Epidemiology Report 85: Reporting period ending 10 March 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

2

COVID-19 Australia : Epidemiology Report 84: Reporting period ending 11 February 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

3

Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults : a Nordic cohort study

enthalten in: European heart journal | 2024

von Hviid, A. | Nieminen, T. | Pihlström, N. | +9

4

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients : Single center experience

enthalten in: Medicina clinica | 2024

von Huguet, M. | Boigues, M. | Sorigué, M. | +20

5

COVID-19 Australia : Epidemiology Report 83: Reporting period ending 14 January 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

6

COVID-19 vaccines and adverse events of special interest : A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

enthalten in: Vaccine | 2024

von Faksova, K. | Walsh, D. | Jiang, Y. | +32

7

Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines : a nationwide cohort study using an emulated target trial approach

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Choi, M. | Na, Y. | Hyun, H. | +10

8

COVID-19 Australia : Epidemiology Report 81: Reporting period ending 19 November 2023

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Section

9

COVID-19 Australia : Epidemiology Report 82: Reporting period ending 17 December 2023

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Section

10

Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients : A post-hoc analysis of the RECOVAC-IR observational study

enthalten in: Free radical biology & medicine | 2024

von van Eijk, L. | Bourgonje, A. | Messchendorp, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[68]